Wells Fargo raised the firm’s price target on Cigna (CI) to $370 from $355 and keeps an Equal Weight rating on the shares as the firm updates Managed Care estimates post-election. All estimates assume the expiration of enhanced exchange subsidies for 2026, Wells notes. The firm believes Medicare Advantage risk/reward improves with Republicans, although areas of concern still exist.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Omega exits stakes in Devon, Las Vegas Sands, KBR, and Paramount Global
- Cigna (NYSE:CI) Surges after Saying It Will Not Buy Humana
- Cigna drops pursuit of Humana: Morning Buzz
- Early notable gainers among liquid option names on November 11th
- Morning Movers: Cigna climbs after confirming not pursuing Humana deal